Proteomic assessment of the acute phase of dystrophin deficiency in mdx mice.
about
The biochemical and mass spectrometric profiling of the dystrophin complexome from skeletal muscleProteomic profiling of the dystrophin-deficient mdx phenocopy of dystrophinopathy-associated cardiomyopathyRescue of dystrophic skeletal muscle by PGC-1α involves a fast to slow fiber type shift in the mdx mouseIsobaric Tagging-Based Quantification for Proteomic Analysis: A Comparative Study of Spared and Affected Muscles from mdx Mice at the Early Phase of DystrophyApplication of fluorescence two-dimensional difference in-gel electrophoresis as a proteomic biomarker discovery tool in muscular dystrophy researchNew pathobiochemical insights into dystrophinopathy from the proteomics of senescent mdx mouse muscleAffinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophiesQuantitative proteomic analysis reveals metabolic alterations, calcium dysregulation, and increased expression of extracellular matrix proteins in laminin α2 chain-deficient muscle.Simultaneous Pathoproteomic Evaluation of the Dystrophin-Glycoprotein Complex and Secondary Changes in the mdx-4cv Mouse Model of Duchenne Muscular DystrophyProfiling of age-related changes in the tibialis anterior muscle proteome of the mdx mouse model of dystrophinopathyProteomics reveals drastic increase of extracellular matrix proteins collagen and dermatopontin in the aged mdx diaphragm model of Duchenne muscular dystrophyLong-term wheel running compromises diaphragm function but improves cardiac and plantarflexor function in the mdx mouseComparative proteomic profiling of soleus, extensor digitorum longus, flexor digitorum brevis and interosseus muscles from the mdx mouse model of Duchenne muscular dystrophyConcurrent Label-Free Mass Spectrometric Analysis of Dystrophin Isoform Dp427 and the Myofibrosis Marker Collagen in Crude Extracts from mdx-4cv Skeletal Muscles.Circulating Biomarkers for Duchenne Muscular Dystrophy.Proteomic identification of biomarkers of skeletal muscle disorders.The physiological response of protease inhibition in dystrophic muscle.Chaperoning heat shock proteins: proteomic analysis and relevance for normal and dystrophin-deficient muscle.Pathoproteomic profiling of the skeletal muscle matrisome in dystrophinopathy associated myofibrosis.Uncovering the exercise-related proteome signature in skeletal muscle.Progressive muscle proteome changes in a clinically relevant pig model of Duchenne muscular dystrophy.Understanding the molecular consequences of inherited muscular dystrophies: advancements through proteomic experimentation.Reduction in mdx mouse muscle degeneration by low-intensity endurance exercise: a proteomic analysis in quadriceps muscle of exercised compared with sedentary mdx mice.PGC-1α gene transfer improves muscle function in dystrophic muscle following prolonged disease progress.Liver and skeletal muscle mitochondria proteomes are altered in pigs divergently selected for residual feed intake.Proteomic profiling of cardiomyopathic tissue from the aged mdx model of Duchenne muscular dystrophy reveals a drastic decrease in laminin, nidogen and annexin.Rescue of dystrophic skeletal muscle by PGC-1α involves restored expression of dystrophin-associated protein complex components and satellite cell signaling.Proteomic profiling of muscle fibre type shifting in neuromuscular diseases.[Molecular pathogenesis of Duchenne muscular dystrophy-related fibrosis].Comparative Label-Free Mass Spectrometric Analysis of Mildly versus Severely Affected mdx Mouse Skeletal Muscles Identifies Annexin, Lamin, and Vimentin as Universal Dystrophic Markers.
P2860
Q26770343-EA1E2242-B13D-4C56-BA17-DC17236218EBQ27006945-DDF8C092-DBA6-4C2F-8BAB-595B352C1D73Q27310125-5E83ECF2-52F2-4E92-8D5C-4E6334AF0385Q28534074-1D71BC76-9F8A-424D-B6D4-03B4BBC6FDC3Q33565229-AF67F2A8-587F-424F-9E22-804D41A22005Q33703934-E59E1459-B8AE-433E-A063-443D0493BC8EQ33991470-2630C005-8C58-4396-91FD-5599A7EBE930Q35201194-C0925EBA-73EE-42F7-AAA9-60B2FD3BA7D7Q35837856-E8CAB3FE-C8CC-45D2-BFEE-5FF93F6CFA41Q36316393-67C31B6A-2A8E-4C5D-99EC-6FF5BCE62A1FQ36613670-5162B2A1-94C5-4112-B32D-F72E1DF8DEB6Q37147219-20DAA009-6242-42FD-AA54-0223E4BEBB99Q37196136-E7EC8186-55EB-44A1-A5A1-A1678E07887DQ37566483-CD7FC644-4C9D-4457-9F3A-BDFD3BAD29EEQ37610530-D77B5045-E89C-4E5D-B400-F6C20B1F0476Q38079622-1236073E-A94F-41AC-899F-30E31E1816F0Q38104503-5A9243DD-B7E1-415E-B993-E1FCA478CB32Q38217473-B5EF4C65-2EBD-4254-B8BA-9B32B0A5715FQ38563300-1246A7C8-64A9-458D-AC3D-06A34CE742CBQ38657767-CBEEEACB-402A-48F6-8606-4917783F95FCQ38820669-FE2CFD99-38CE-49E9-B5F2-613A8211CBB3Q38850056-2D7AF689-2DC8-4D87-823E-E63A00D9716EQ40728538-DED4EEDC-0CAA-4F13-BCA9-EB270CC84B8FQ41487839-41475707-B6C5-4520-8C6E-292C706F96B5Q43657650-28E8FDDF-EB6B-454B-96F4-703871D9E861Q44232941-C4F24939-DD46-4043-899A-E16B6AC005BBQ45080100-0F70B3DF-6317-41C0-9972-62A5740DF6CEQ51664676-A821D6AB-D5C5-4D4B-A689-BA36725430D6Q52925630-B605740F-7EB3-49E9-881E-74988AAD774CQ53457776-F3583E9C-DDDA-4A55-85C0-6B1AEB9270B6
P2860
Proteomic assessment of the acute phase of dystrophin deficiency in mdx mice.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Proteomic assessment of the acute phase of dystrophin deficiency in mdx mice.
@en
Proteomic assessment of the acute phase of dystrophin deficiency in mdx mice.
@nl
type
label
Proteomic assessment of the acute phase of dystrophin deficiency in mdx mice.
@en
Proteomic assessment of the acute phase of dystrophin deficiency in mdx mice.
@nl
prefLabel
Proteomic assessment of the acute phase of dystrophin deficiency in mdx mice.
@en
Proteomic assessment of the acute phase of dystrophin deficiency in mdx mice.
@nl
P2093
P2860
P1476
Proteomic assessment of the acute phase of dystrophin deficiency in mdx mice
@en
P2093
D Gardan-Salmon
S M Lonergan
P2860
P2888
P304
P356
10.1007/S00421-011-1906-3
P577
2011-03-16T00:00:00Z